<DOC>
	<DOCNO>NCT00617552</DOCNO>
	<brief_summary>The purpose study determine whether TZP-101 effective management post operative ileus subject undergo major open abdominal surgery ( i.e . partial large bowel resection ) .</brief_summary>
	<brief_title>Safety Efficacy IV Infusion TZP-101 POI After Major Open Abdominal Surgery</brief_title>
	<detailed_description>Subjects randomize accord adaptive randomization procedure .</detailed_description>
	<criteria>Subjects meet follow inclusion criterion may enrol study : Male Female , 18 80 year age , inclusive If female , postmenopausal past 12 month , surgically sterile ( i.e . tubal ligation , hysterectomy ) , use adequate method birth control ( i.e. , oral contraceptive , double barrier method , IUD cover sterilize partner Subject schedule undergo partial large bowel resection primary anastomosis See Appendix II Subject 's body weight ≤100kg Subject schedule receive postoperative pain management i.v . opioids Subject schedule nasogastric tube remove end surgery Subject schedule offer liquid postoperative day 1 Subject schedule encouraged ambulation postoperative day 1 Subject schedule offer solid food postoperative day 2 Subjects meet follow exclusion criterion may enrol study : A marked baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 ( men ) / &gt; 470 ( woman ) millisecond ) Subject history additional risk factor Torsades de Pointes ( heart failure , hypokalemia , family history Long QT Syndrome ) Subject require use concomitant medication prolongs QT interval List provide Study Procedures Manual Subject require use concomitant medication know interact isoenzyme CYP3A4 Subject complete bowel obstruction Subject schedule receive thoracic epidural Subject schedule receive total colectomy , colostomy , ileostomy Subject schedule receive low anterior resection Subject schedule laparoscopic procedure Subject schedule receive prophylactic antiemetic post surgery ; however subject may receive intraoperatively part anesthesia protocol postoperative antiemetic symptomatic treatment Subject significant impairment liver renal function ( ALT/AST 2 ½ time upper limit normal ; creatinine clearance &lt; 50mL/min . ) Subject psychiatric disorder cognitive impairment would interfere participation study Subject severe cardiovascular , pulmonary , hematological disease Subject participate investigational study 30 day prior receive TZP101 90 day prior study initiation Subject pregnant ( confirm quantitative serum pregnancy test ) breastfeeding Subject know history Hep B , Hep C HIV Subject known history drug alcohol abuse Subject recent , adult history clinically significant hypersensitivity reaction ( ) drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>postoperative ileus</keyword>
	<keyword>POI</keyword>
	<keyword>major open abdominal surgery</keyword>
</DOC>